Found: 17
Select item for more details and to access through your institution.
Correction to: Association between circulating alpha-1 antitrypsin polymers and lung and liver disease.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
Correction to: Association between circulating alpha-1 antitrypsin polymers and lung and liver disease.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Association between circulating alpha-1 antitrypsin polymers and lung and liver disease.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Prevalence and Risk Factors of MASLD and Liver Fibrosis amongst the Penitentiary Population in Catalonia: The PRISONAFLD Study.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 23, p. 7276, doi. 10.3390/jcm12237276
- By:
- Publication type:
- Article
When Sugar Reaches the Liver: Phenotypes of Patients with Diabetes and NAFLD.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 12, p. 3286, doi. 10.3390/jcm11123286
- By:
- Publication type:
- Article
Partial restoration of immune response in Hepatitis C patients after viral clearance by direct-acting antiviral therapy.
- Published in:
- PLoS ONE, 2021, v. 15, n. 7, p. 1, doi. 10.1371/journal.pone.0254243
- By:
- Publication type:
- Article
Control of occult hepatitis B virus infection.
- Published in:
- Advances in Laboratory Medicine / Avances en Medicina de Laboratorio, 2022, v. 3, n. 4, p. 321, doi. 10.1515/almed-2022-0065
- By:
- Publication type:
- Article
Revisión de la infección oculta por el virus de la hepatitis B.
- Published in:
- Advances in Laboratory Medicine / Avances en Medicina de Laboratorio, 2022, v. 3, n. 4, p. 331, doi. 10.1515/almed-2021-0084
- By:
- Publication type:
- Article
Infección por SARS-CoV-2 y su impacto en la enfermedad hepática.
- Published in:
- Advances in Laboratory Medicine / Avances en Medicina de Laboratorio, 2022, v. 3, n. 2, p. 134, doi. 10.1515/almed-2022-0010
- By:
- Publication type:
- Article
Impact of SARS-CoV-2 infection on liver disease.
- Published in:
- Advances in Laboratory Medicine / Avances en Medicina de Laboratorio, 2022, v. 3, n. 2, p. 126, doi. 10.1515/almed-2022-0037
- By:
- Publication type:
- Article
New variants of alpha-1-antitrypsin: structural simulations and clinical expression.
- Published in:
- Respiratory Research, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s12931-022-02271-8
- By:
- Publication type:
- Article
Influence of Type 2 Diabetes in the Association of PNPLA3 rs738409 and TM6SF2 rs58542926 Polymorphisms in NASH Advanced Liver Fibrosis.
- Published in:
- Biomedicines, 2022, v. 10, n. 5, p. 1015, doi. 10.3390/biomedicines10051015
- By:
- Publication type:
- Article
Soluble Angiotensin-Converting Enzyme 2 as a Prognostic Biomarker for Disease Progression in Patients Infected with SARS-CoV-2.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 4, p. 886, doi. 10.3390/diagnostics12040886
- By:
- Publication type:
- Article
Assessing Liver Fibrosis Using the FIB4 Index in the Community Setting.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 12, p. 2236, doi. 10.3390/diagnostics11122236
- By:
- Publication type:
- Article
Recovery of serum testosterone levels is an accurate predictor of survival from COVID-19 in male patients.
- Published in:
- 2022
- By:
- Publication type:
- Journal Article
Harmonization of indirect reference intervals calculation by the Bhattacharya method.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2023, v. 61, n. 2, p. 266, doi. 10.1515/cclm-2022-0439
- By:
- Publication type:
- Article
Accuracy of a sequential algorithm based on FIB-4 and ELF to identify high-risk advanced liver fibrosis at the primary care level.
- Published in:
- Internal & Emergency Medicine, 2024, v. 19, n. 3, p. 745, doi. 10.1007/s11739-023-03441-2
- By:
- Publication type:
- Article